Clinical Cancer Research, Vol 2, Issue 4 623-633, Copyright © 1996 by American Association for Cancer Research

ARTICLES

Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2

GS Wu and WS El-Deiry
Howard Hughes Medical Institute, Laboratory of Molecular Oncology, Department of Medicine and Genetics, University of Pennsylvania School of Medicine and Comprehensive Cancer Center, Philadelphia, USA.

p53 has been implicated as a determinant of chemosensitivity and radiosensitivity. We measured chemosensitivity of human tumor cell lines (n = 11), with or without wild-type p53, following exposure to clinically useful chemotherapeutic drugs (n = 4). Chemosensitivity and apoptosis induction were correlated independently of p53 status or Bcl-2 protein levels in vitro. Wild-type p53 correlated with chemosensitivity in ovarian carcinoma and some Burkitt's lymphoma cells, but not in leukemia or lung cancer. Bcl-2 levels correlated with chemoresistance only in Burkitt's lymphoma. p53-dependent p21(WAF1/CIP1) induction and cell cycle arrest occurred at sublethal doses of chemotherapy, whereas at lethal doses of chemotherapy apoptotic death was observed, consistent with models proposing a relationship between the level of DNA damage versus survival or death. Loss of apoptosis induction was observed in drug-resistant ML-1 and HL-60 leukemia cells, without changes in p53 or Bcl-2. Targeted loss of p53 protein in H460 lung cancer cells using HPV-16 E6 inhibited the etoposide-induced G1 checkpoint but did not decrease chemosensitivity. Our studies suggest that the simple measurement of apoptosis induction may be a useful predictor of chemosensitivity, at least in vitro, and confirm that p53 status and Bcl-2 expression may be useful predictors of chemosensitivity in certain cell types.

This article has been cited by other articles:

				R. Wang, C. Li, D. Song, G. Zhao, L. Zhao, and Y. Jing Ethacrynic Acid Butyl-Ester Induces Apoptosis in Leukemia Cells through a Hydrogen Peroxide Mediated Pathway Independent of Glutathione S-Transferase P1-1 Inhibition Cancer Res., August 15, 2007; 67(16): 7856 - 7864. [Abstract] [Full Text] [PDF]

				N. Georgopoulou, C. Hurel, P. K. Politis, M. Gaitanou, R. Matsas, and D. Thomaidou BM88 Is a Dual Function Molecule Inducing Cell Cycle Exit and Neuronal Differentiation of Neuroblastoma Cells via Cyclin D1 Down-regulation and Retinoblastoma Protein Hypophosphorylation J. Biol. Chem., November 3, 2006; 281(44): 33606 - 33620. [Abstract] [Full Text] [PDF]

				J.-Y. Zhou, Y. Liu, and G. S. Wu The Role of Mitogen-Activated Protein Kinase Phosphatase-1 in Oxidative Damage-Induced Cell Death. Cancer Res., May 1, 2006; 66(9): 4888 - 4894. [Abstract] [Full Text] [PDF]

				X. Lin and S. B. Howell DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance Mol. Cancer Ther., May 1, 2006; 5(5): 1239 - 1247. [Abstract] [Full Text] [PDF]

				S. M. O'Brien, C. C. Cunningham, A. K. Golenkov, A. G. Turkina, S. C. Novick, and K. R. Rai Phase I to II Multicenter Study of Oblimersen Sodium, a Bcl-2 Antisense Oligonucleotide, in Patients With Advanced Chronic Lymphocytic Leukemia J. Clin. Oncol., October 20, 2005; 23(30): 7697 - 7702. [Abstract] [Full Text] [PDF]

				A. Grimberg, C. M. Coleman, T. F. Burns, B. P. Himelstein, C. J. Koch, P. Cohen, and W. S. El-Deiry p53-Dependent and p53-Independent Induction of Insulin-Like Growth Factor Binding Protein-3 by Deoxyribonucleic Acid Damage and Hypoxia J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3568 - 3574. [Abstract] [Full Text] [PDF]

				L. Xia, D. Chen, R. Han, Q. Fang, S. Waxman, and Y. Jing Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells Mol. Cancer Ther., March 1, 2005; 4(3): 381 - 388. [Abstract] [Full Text] [PDF]

				L. Benimetskaya, J. C. Lai, A. Khvorova, S. Wu, E. Hua, P. Miller, L.-M. Zhang, and C. A. Stein Relative Bcl-2 Independence of Drug-Induced Cytotoxicity and Resistance in 518A2 Melanoma Cells Clin. Cancer Res., December 15, 2004; 10(24): 8371 - 8379. [Abstract] [Full Text] [PDF]

				M. A. I. Abou El Hassan, I. van der Meulen-Muileman, S. Abbas, and F. A. E. Kruyt Conditionally Replicating Adenoviruses Kill Tumor Cells via a Basic Apoptotic Machinery-Independent Mechanism That Resembles Necrosis-Like Programmed Cell Death J. Virol., November 15, 2004; 78(22): 12243 - 12251. [Abstract] [Full Text] [PDF]

				P. A. Svingen, D. Loegering, J. Rodriquez, X. W. Meng, P. W. Mesner Jr., S. Holbeck, A. Monks, S. Krajewski, D. A. Scudiero, E. A. Sausville, et al. Components of the Cell Death Machine and Drug Sensitivity of the National Cancer Institute Cell Line Panel Clin. Cancer Res., October 15, 2004; 10(20): 6807 - 6820. [Abstract] [Full Text] [PDF]

				M. S. Ricci, Z. Jin, M. Dews, D. Yu, A. Thomas-Tikhonenko, D. T. Dicker, and W. S. El-Deiry Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity Mol. Cell. Biol., October 1, 2004; 24(19): 8541 - 8555. [Abstract] [Full Text] [PDF]

				M. B. Flick, D. O'Malley, T. Rutherford, S. Rodov, M. Kamsteeg, X.-Y. Hao, P. Schwartz, B. M. Kacinski, and G. Mor Apoptosis-Based Evaluation of Chemosensitivity in Ovarian Cancer Patients Reproductive Sciences, May 1, 2004; 11(4): 252 - 259. [Abstract] [PDF]

				M. Li, J.-Y. Zhou, Y. Ge, L. H. Matherly, and G. S. Wu The Phosphatase MKP1 Is a Transcriptional Target of p53 Involved in Cell Cycle Regulation J. Biol. Chem., October 17, 2003; 278(42): 41059 - 41068. [Abstract] [Full Text] [PDF]

				J. C. Cusack Jr. Overcoming Antiapoptotic Responses to Promote Chemosensitivity in Metastatic Colorectal Cancer to the Liver Ann. Surg. Oncol., October 1, 2003; 10(8): 852 - 862. [Abstract] [Full Text] [PDF]

				J. K. Sax and W. S. El-Deiry Identification and Characterization of the Cytoplasmic Protein TRAF4 as a p53-regulated Proapoptotic Gene J. Biol. Chem., September 19, 2003; 278(38): 36435 - 36444. [Abstract] [Full Text] [PDF]

				E. A. Choi, H. Lei, D. J. Maron, J. M. Wilson, J. Barsoum, D. L. Fraker, W. S. El-Deiry, and F. R. Spitz Stat1-dependent Induction of Tumor Necrosis Factor-related Apoptosis-inducing Ligand and the Cell-Surface Death Signaling Pathway by Interferon {beta} in Human Cancer Cells Cancer Res., September 1, 2003; 63(17): 5299 - 5307. [Abstract] [Full Text] [PDF]

				O. S. Frankfurt and A. Krishan Microplate Screening for Apoptosis with Antibody to Single-Stranded DNA Distinguishes Anticancer Drugs from Toxic Chemicals J Biomol Screen, April 1, 2003; 8(2): 185 - 190. [Abstract] [PDF]

				T. Petit, D. J. Bearss, D. A. Troyer, R. M. Munoz, and J. J. Windle p53-independent Response to Cisplatin and Oxaliplatin in MMTV-ras Mouse Salivary Tumors Mol. Cancer Ther., February 1, 2003; 2(2): 165 - 171. [Abstract] [Full Text] [PDF]

				T. K. MacLachlan and W. S. El-Deiry Apoptotic threshold is lowered by p53 transactivation of caspase-6 PNAS, July 9, 2002; 99(14): 9492 - 9497. [Abstract] [Full Text] [PDF]

				T. K. MacLachlan, R. Takimoto, and W. S. El-Deiry BRCA1 Directs a Selective p53-Dependent Transcriptional Response towards Growth Arrest and DNA Repair Targets Mol. Cell. Biol., June 15, 2002; 22(12): 4280 - 4292. [Abstract] [Full Text] [PDF]

				Z. Ding, R. E. Parchment, P. M. LoRusso, J.-Y. Zhou, J. Li, T. S. Lawrence, Y. Sun, and G. S. Wu The Investigational New Drug XK469 Induces G2-M Cell Cycle Arrest by p53-dependent and -independent Pathways Clin. Cancer Res., November 1, 2001; 7(11): 3336 - 3342. [Abstract] [Full Text] [PDF]

				J. C. Cusack Jr., R. Liu, M. Houston, K. Abendroth, P. J. Elliott, J. Adams, and A. S. Baldwin Jr. Enhanced Chemosensitivity to CPT-11 with Proteasome Inhibitor PS-341:: Implications for Systemic Nuclear Factor-{{kappa}}B Inhibition Cancer Res., May 1, 2001; 61(9): 3535 - 3540. [Abstract] [Full Text]

				K. S. Srivenugopal, J. Shou, S. R. S. Mullapudi, F. F. Lang Jr., J. S. Rao, and F. Ali-Osman Enforced Expression of Wild-Type p53 Curtails the Transcription of the O6-Methylguanine-DNA Methyltransferase Gene in Human Tumor Cells and Enhances Their Sensitivity to Alkylating Agents Clin. Cancer Res., May 1, 2001; 7(5): 1398 - 1409. [Abstract] [Full Text]

				X. Lin, K. Ramamurthi, M. Mishima, A. Kondo, R. D. Christen, and S. B. Howell p53 Modulates the Effect of Loss of DNA Mismatch Repair on the Sensitivity of Human Colon Cancer Cells to the Cytotoxic and Mutagenic Effects of Cisplatin Cancer Res., February 1, 2001; 61(4): 1508 - 1516. [Abstract] [Full Text]

				P. A. Svingen, J. E. Karp, S. Krajewski, P. W. Mesner Jr, S. D. Gore, P. J. Burke, J. C. Reed, Y. A. Lazebnik, and S. H. Kaufmann Evaluation of Apaf-1 and procaspases-2, -3, -7, -8, and -9 as potential prognostic markers in acute leukemia Blood, December 1, 2000; 96(12): 3922 - 3931. [Abstract] [Full Text] [PDF]

				J. C. Cusack Jr., R. Liu, and A. S. Baldwin Jr. Inducible Chemoresistance to 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) in Colorectal Cancer Cells and a Xenograft Model Is Overcome by Inhibition of Nuclear Factor-{{kappa}}B Activation Cancer Res., May 1, 2000; 60(9): 2323 - 2330. [Abstract] [Full Text]

				K. E. Pestell, S. M. Hobbs, J. C. Titley, L. R. Kelland, and M. I. Walton Effect of p53 Status on Sensitivity to Platinum Complexes in a Human Ovarian Cancer Cell Line Mol. Pharmacol., March 1, 2000; 57(3): 503 - 511. [Abstract] [Full Text]

				K. Kim, M. J. Fisher, S.-Q. Xu, and W. S. El-Deiry Molecular Determinants of Response to TRAIL in Killing of Normal and Cancer Cells Clin. Cancer Res., February 1, 2000; 6(2): 335 - 346. [Abstract] [Full Text]

				T. K. MacLachlan, K. Somasundaram, M. Sgagias, Y. Shifman, R. J. Muschel, K. H. Cowan, and W. S. El-Deiry BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression J. Biol. Chem., January 28, 2000; 275(4): 2777 - 2785. [Abstract] [Full Text] [PDF]

				B. Kurdoglu, N. Cheong, J. Guan, B. W. Corn, W. J. Curran Jr., and G. Iliakis Apoptosis as a Predictor of Paclitaxel-induced Radiosensitization in Human Tumor Cell Lines Clin. Cancer Res., September 1, 1999; 5(9): 2580 - 2587. [Abstract] [Full Text] [PDF]

				S.-Y. Sun, P. Yue, G. S. Wu, W. S. El-Deiry, B. Shroot, W. K. Hong, and R. Lotan Implication of p53 in Growth Arrest and Apoptosis Induced by the Synthetic Retinoid CD437 in Human Lung Cancer Cells Cancer Res., June 1, 1999; 59(12): 2829 - 2833. [Abstract] [Full Text] [PDF]

				R. J. Pietras, J. C. Poen, D. Gallardo, P. N. Wongvipat, H. J. Lee, and D. J. Slamon Monoclonal Antibody to HER-2/neuReceptor Modulates Repair of Radiation-induced DNA Damage and Enhances Radiosensitivity of Human Breast Cancer Cells Overexpressing This Oncogene Cancer Res., March 1, 1999; 59(6): 1347 - 1355. [Abstract] [Full Text] [PDF]

				S. H. Kaufmann, J. E. Karp, P. A. Svingen, S. Krajewski, P. J. Burke, S. D. Gore, and J. C. Reed Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse Blood, February 1, 1998; 91(3): 991 - 1000. [Abstract] [Full Text] [PDF]

				R. E. Barrington, M. A. Subler, E. Rands, C. A. Omer, P. J. Miller, J. E. Hundley, S. K. Koester, D. A. Troyer, D. J. Bearss, M. W. Conner, et al. A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis Mol. Cell. Biol., January 1, 1998; 18(1): 85 - 92. [Abstract] [Full Text]

				L. M. Martins, P. W. Mesner, T. J. Kottke, G. S. Basi, S. Sinha, J. S. Tung, P. A. Svingen, B. J. Madden, A. Takahashi, D. J. McCormick, et al. Comparison of Caspase Activation and Subcellular Localization in HL-60 and K562 Cells Undergoing Etoposide-Induced Apoptosis Blood, December 1, 1997; 90(11): 4283 - 4296. [Abstract] [Full Text] [PDF]

				T. K. MacLachlan, B. C. Dash, D. T. Dicker, and W. S. El-Deiry Repression of BRCA1 through a Feedback Loop Involving p53 J. Biol. Chem., October 6, 2000; 275(41): 31869 - 31875. [Abstract] [Full Text] [PDF]